Greater trochanteric pain syndrome: focused shockwave therapy versus an ultrasound guided injection: a randomised control trial

Heaver, Catriona; Pinches, Megan; Kuiper, Jan Herman; Thomas, Geraint; Lewthwaite, Simon; Burston, Ben J; Banerjee, Robin D

Abstract

Greater trochanteric pain syndrome (GTPS) is a common problem with an incidence of 1.8–5.6 per 1000 population. Physiotherapy, anti-inflammatories, corticosteroid injections and surgery have all been described in the management of GTPS, with limited, temporal success. Extracorporeal shockwave therapy (ESWT) has been proposed as a potential non-invasive management option for this difficult presentation.

Citation

Heaver, C., Pinches, M., Kuiper, J. H., Thomas, G., Lewthwaite, S., Burston, B. J., & Banerjee, R. D. (2023). Greater trochanteric pain syndrome: focused shockwave therapy versus an ultrasound guided injection: a randomised control trial. Hip International, 33(3), 490-499. https://doi.org/10.1177/11207000211060396

• Journal Article Type: Article
• Acceptance Date: Nov 17, 2021
• Online Publication Date: Nov 17, 2021
• Publication Date: 2023-05
• Deposit Date: Jun 2, 2023
• Journal: HIP International
• Print ISSN: 1120-7000
• Electronic ISSN: 1724-6067
• Publisher: Wichtig
• Peer Reviewed: Peer Reviewed
• Volume: 33
• Issue: 3
• Pages: 490-499
• DOI: https://doi.org/10.1177/11207000211060396
• Keywords: Orthopedics and Sports Medicine; Surgery